Therapeutic Approaches for Blastic Plasmacytoid Dendritic Cell Neoplasm: Allogeneic Hematopoietic Cell Transplantation and Novel Therapies

Blastic plasmacytoid dendritic cell neoplasm (BPDCN) is a clinically aggressive hematologic malignancy derived from precursors of plasmacytoid dendritic cells. There is no established standard therapy for BPDCN and the efficacy of conventional chemotherapy is limited, with an anticipated median over...

Descripción completa

Detalles Bibliográficos
Autores principales: Kharfan-Dabaja, Mohamed A., Pemmaraju, Naveen, Mohty, Mohamad
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Atlantis Press 2019
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432376/
https://www.ncbi.nlm.nih.gov/pubmed/34595405
http://dx.doi.org/10.2991/chi.d.190218.001

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8432376/
https://www.ncbi.nlm.nih.gov/pubmed/34595405
http://dx.doi.org/10.2991/chi.d.190218.001

Ejemplares similares